Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Sharon R. Myers"'
Autor:
Andrew C Adams, Carolyn A Halstead, Barbara C Hansen, Armando R Irizarry, Jennifer A Martin, Sharon R Myers, Vincent L Reynolds, Holly W Smith, Victor J Wroblewski, Alexei Kharitonenkov
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e65763 (2013)
Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that represents a promising target for the treatment of several metabolic diseases. Administration of recombinant wild type FGF21 to diabetic animals leads to a dramatic improvement i
Externí odkaz:
https://doaj.org/article/aa7072c111da48b3972a0347777f6348
Autor:
Amy L. Cox, Ronald E. Chance, David S. McClellan, Sharon R. Myers, Mark L. Brader, Allen H. Pekar, David B. Flora, Lynnie A. Irwin, Muppalla Sukumar
Publikováno v:
Nature Biotechnology. 20:800-804
The ability to tailor the release profile of a drug by manipulating its formulation matrix offers important therapeutic advantages. We show here that human insulin can be cocrystallized at preselected ratios with the fully active lipophilically modif
Autor:
Kevin A. Destrampe, Dawn Marie Rebhun, Dean K. Clodfelter, Allen H. Pekar, Sharon R. Myers, Henry A. Havel, Mark L. Brader
Publikováno v:
Pharmaceutical Research. 15:254-262
Purpose. To utilize an acylated peptide as a model system to investigate the relationships among solution peptide conformation, non-covalent self-association, subcutaneous absorption and bioavailability under pharmaceutically relevant solution formul
Autor:
Doss W. Neal, Sharon R Myers, Cynthia C. Connolly, Jonathan B. Jaspan, R. T. Frizzell, Alan D. Cherrington, Stephen N. Davis, D. W. Biggers, E. M. Jones
Publikováno v:
Diabetes. 42:1253-1261
Previous studies have demonstrated the importance of the brain in directing counterregulation during insulin-induced hypoglycemia in dogs. The capability of selective carotid or vertebrobasilar hypoglycemia in triggering counterregulation was assesse
Publikováno v:
Journal of Clinical Investigation. 87:930-939
To examine the relationship between net hepatic glucose uptake (NHGU) and the insulin level and to determine the effects of portal glucose delivery on that relationship, NHGU was evaluated at three different insulin levels in seven 42-h-fasted, consc
Autor:
Michael P. Diamond, Sharon R Myers, Bess A. Adkins-Marshall, Randy Stinsen, Alan D. Cherrington, Phillip E. Williams
Publikováno v:
Metabolism. 40:66-71
The aim of this study was to examine the influence of small changes in glucagon on hepatic glucose production during a euglycemic, hyperinsulinemic clamp. During 1.0 mU/kg.min insulin infusion, euglycemia was maintained by glucose infusion and glucag
Autor:
Phil Williams, Bess A. Adkins-Marshall, Sharon R Myers, Keith Triebwasser, Ben Floyd, Alan D. Cherrington, G K Hendrick
Publikováno v:
Diabetes. 39:87-95
In the presence of fixed basal levels of insulin, the route of intravenous glucose delivery (portal vs. peripheral) determines whether net hepatic glucose uptake (NHGU) occurs. Our aims were to determine if the route of intravenous glucose delivery a
Autor:
Carolyn A. Halstead, Vincent L. Reynolds, Sharon R. Myers, Holly W. Smith, Armando R. Irizarry, Alexei Kharitonenkov, Victor J. Wroblewski, Barbara C. Hansen, Andrew C. Adams, Jennifer A. Martin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 6, p e65763 (2013)
PLoS ONE, Vol 8, Iss 6, p e65763 (2013)
Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that represents a promising target for the treatment of several metabolic diseases. Administration of recombinant wild type FGF21 to diabetic animals leads to a dramatic improvement i
Publikováno v:
Diabetes. 45(12)
We have previously demonstrated that the liver can release glucose in response to insulin-induced hypoglycemia, despite the absence of glucagon, epinephrine, cortisol, and growth hormone. The aim of this study was to determine whether this is activat
Autor:
Cynthia C. Connolly, Alan D. Cherrington, G. K. Hendrick, Bess A. Adkins-Marshall, Doss W. Neal, Phillip E. Williams, Sharon R Myers, R. B. Adkins, Jordan Asher, Michael J. Pagliassotti
Publikováno v:
The American journal of physiology. 262(5 Pt 1)
Net hepatic glucose uptake (NHGU) is much greater during oral or intraportal glucose loading than during peripheral intravenous glucose delivery even when similar glucose loads and hormone levels reaching the liver are maintained. To determine whethe